PEPTIDE CORTEXThe library
← The library

Epitalon / Epithalon

researchLongevity
Evidence grade
DResearch/compounded/adjunct (no established FDA indication)
Cardiovascular · 0–5 · separate axis
1
Read first · not dosing instructions

Educational and research reference only. Not medical advice, not a recommendation, and not dosing instructions for any person. Figures are reported from the cited source and may be wrong or out of date. Research peptides are not approved for human use. Adults 18+. Consult a licensed physician before any decision about your health.

PurposeLongevity / Circadian
MechanismPeptide studied for telomere/circadian effects
EffectsPeptide studied for telomere/circadian effects
DosingNo human dose established.
Bottom linePopular in research/compounding; human safety/benefit not well-established.
Protocols · as published1 sourced
Community protocol — not clinically establishedCommunity guide
RouteSubcutaneous
FrequencyDaily during a short course, evening
StartingNo titration; two patterns
EscalationNone
TargetPattern 1: 5 mg/day SC x 20 days. Pattern 2: 10 mg/day SC x 10 days. About 100 mg per course either way.
Cycle10-20 days on; 4-6 months off; 2-3 courses/year

"There is no large, blinded human trial that tested a specific epitalon injection dose." The 100 mg course mirrors a Russian study of epithalamin, a pineal EXTRACT (10 mg IM daily for 10 days) — a different product from synthetic epitalon.

Batches on filenone

No tested batches on file.

Read with10
Cautions & interactions

Not FDA-approved; unknown human efficacy/safety

No well-established interaction profile for non-approved peptides; avoid combining multiple research compounds; discuss meds with clinician.

CV 1 of 5 — No solid direct cardiovascular outcomes evidence; any benefit is indirect or unproven.